Tyra Biosciences closes IPO of 12.42M shares at $16, raising $198.7M gross proceeds

Tyra Biosciences, Inc.

IPO of 12.42M shares (includes full underwriter option) at $16.00/share closed on Sep 17, 2021.
Gross proceeds of $198.7M before underwriting discounts and offering expenses.
Amended charter to increase authorized common to 500M shares, authorize 50M preferred shares, and establish classified board.
Bylaws amended to set procedures for stockholder proposals and director nominations effective upon IPO closing.
Company is an emerging growth company under the JOBS Act.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.